Measuring age-related changes in dopamine D2 receptors with 11C-raclopride and 18F-N-methylspiroperidol

Psychiatry Research - Neuroimaging

Volumn 67, Issue 1, 1996, Pages 11-16

  Volkow, Nora D ^a,b,c   Wang, Gene Jack ^a   Fowler, Joanna S ^a   Logan, Jean ^a   Gatley, Samuel J ^a   MacGregor, Robert R ^a   Schlyer, David J ^a   Hitzemann, Robert ^b   Wolf, Alfred P ^a  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

Aging; Neurodegeneration; Positron emission tomography; Striatum

Indexed keywords

3 METHYLSPIPERONE; DOPAMINE 2 RECEPTOR; FLUORINE 18; RACLOPRIDE;

ADULT; AGED; AGING; ARTICLE; BRAIN SCINTISCANNING; CEREBELLUM; CORPUS STRIATUM; DRUG RECEPTOR BINDING; FEMALE; HUMAN; HUMAN EXPERIMENT; ISOTOPE LABELING; MALE; NERVE DEGENERATION; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR DENSITY;

ADULT; AGE FACTORS; AGED; AGING; CEREBELLUM; CORPUS STRIATUM; DOPAMINE AGONISTS; FEMALE; HUMANS; LIGANDS; MALE; MIDDLE AGED; NERVE DEGENERATION; RACLOPRIDE; RECEPTORS, DOPAMINE D2; SALICYLAMIDES; SPIPERONE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030060954     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/0925-4927(96)02809-0     Document Type: Article

References (30)

1. 11C-raclopride. Arch Neurol 50, 474-480.
2. 76Br]bromospiperone binding sites demonstrated by positron emission tomography in progressive supranuclear palsy. J Cereb Blood Flow Metab 6, 131-136.
3. Battistin, L., Rigo, A., Bracco, F., Dam, M. and Pizzolato, G. (1987) Metabolic aspects of aging brain and related disorders. Gerontology 33, 253-258.
4. DeKeyser, J., Ebinger, G. and Vauquelin, G. (1990) Age-related changes in the human nigrostriatal dopaminergic system Ann Neurol 27, 157-161.
5. 3H-N-methylspiperone to dopamine and serotonin receptors. Life Sci 40, 987-995.
6. 2-dopamine receptors is subject to economic correction. Gerontology 37, 244-252.
7. Logan, J., Fowler, J.S., Volkow, N.D., Wolf, A.P., Dewey, S.L., Schlyer, D., MacGregor, R.R., Hitzemann, R., Bendriem, B., Galley, S.J. and Christman, D.R. (1990) Graphical analysis of reversible binding from time activity measurements. J Cereb Blood Flow Metab 10, 740-747.
8. 11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data. J Cereb Blood Flow Metab 14, 995-1010.
9. McGeer, P.L., McGeer, E.G. and Suzuki, J.S. (1977) Aging and extrapyramidal function. Arch Neurol 34, 33-35.
10. 3 receptors. Eur J Pharmacol 238, 121-125.
11. 2 dopamine binding sites in human brain during aging. Neurobiol Aging 8, 195-201.
12. 125I]epidepride. Eur J Pharmacol 227, 443-445.
13. Palmer, A.M. and DeKosky, S.T. (1993) Monoamine neurons in aging and Alzheimer's Disease. J Neural Transm 91, 135-159.
14. Richards, M., Stern, Y. and Mayeux, R. (1993) Subtle extrapyramidal signs can predict the development of dementia in elderly individuals. Neurology 43, 2184-2188.
15. 11C-raclopride. J Cereb Blood Flow Metab 13, 310-314.
16. 2 receptors. Brain Res 508, 349-352.
17. Roth, G.S. and Joseph, J.A. (1988) Peculiarities of the effects of hormones and transmitters during aging: modulation of changes in dopaminergic action. Gerontology 34, 22-28.
18. Seeman, P., Bzowe, N.H., Guan, H.G., Bergeron, C., Becker, L.E., Reynolds, G.P., Bird, E.D., Riederer, P., Jellinger, K.J., Watanabe, S. and Tourtellotte, W. (1987) Human brain dopamine receptors in children and aging adults. Synapse 1, 399-404.
19. 4 receptors elevated in schizophrenia. Nature 365, 441-445.
20. 4 receptors in Parkinson's, schizophrenia and control brain striata. Synapse 14, 247-253.
21. Severson, J.A., Marcusson, J., Winblåd, B. and Finch, C.E. (1982) Age-correlated loss of dopaminergic binding sites in human basal ganglia. J Neurochem 39, 1623-1631.
22. 2 receptor occupancy in schizophrenic patients. Biol Psychiatry 23, 653-663.
23. Van Dyck, C.H., Seibyl, J.P., Malison, R.T., Laruelle, M., Wallace, E., Zoghbi, S.S., Ponce, Y.Z., Baldwin, R.M., Charney, D.S., Hoffer, P.B. and Innis, R.B. (1995) Age-related decline in dopamine transporter binding in human striatum with [I-123]β-CIT SPECT. J Nucl Med 36, 1175-1181.
24. 11C-raclopride binding in the human brain. J Nucl Med 34, 609-613.
25. Volkow, N.D., Fowler, J.S., Wang, G.-J., Hitzemann, R., Logan, J., Schlyer, D., Dewey, S. and Wolf, A.P. (1993b) Dopaminergic dysregulation of frontal metabolism may contribute to cocaine addiction. Synapse 14, 169-177.
26. Volkow, N.D., Fowler, J.S., Wang, G.-J., Logan, J., Schlyer, D., MacGregor, R., Hitzemann, R. and Wolf, A.P. (1994) Decreased dopamine transporters with age in healthy human subjects. Ann Neurol 36, 237-239.
27. 2 receptor availability in healthy human subjects. Life Sci 56, 249-253.
28. Woda, A., Alavi, A., Mozley, D. and Galloway, S. (1992) Effects of age on dopamine receptors as measured with SPECT and IBZM. J Nucl Med 33, 897.
29. Wong, D.F., Wagner, H.N., Jr., Dannals, R.F., Links, J.M., Frost, J.J., Ravert, H.T., Wilson, A., Rosenbaum, A., Gjedde, A., Douglass, K.H., Folstein, M., Toung, J.T., Burns, H.D. and Kuhar, M.J. (1984) Effects of age on dopamine and serotonin receptors measured by positron emission tomography in the living brain. Science 226, 1393-1396.
30. Zaleon, C.R. and Guthrie, S.K. Antipsychotic drug use in older adults. (1994) Am J Hosp Pharm 51, 2917-2943.